BioPharmGuy logo
Sponsored By:
Trianni Inc.
Weekly Update Subscription
Emery Pharma
Abraxis Bioscience is defunct.

Fate: Bought by Celgene, June 2010, $2.9B


------------------
If you believe any of this information is incorrect, please let us know.